Acurx Announces Anthrax Susceptibility to ACX-375 Analogues Medical Countermeasures September 26, 2024 …
New Partnerships Boost Decentralized Clinical Trial Capacity for Public Health Emergencies Contracts + Grants August 27, 2024 …
Disappointing Results for Tecovirimat Mpox Trial in the DRC Medical Countermeasures August 15, 2024 …
Lassa Fever Vaccine Study Supports Advancement to Phase I Trial Medical Countermeasures August 14, 2024 …
Are We There Yet? Agent Agnostic Metagenome Sequencing for Biothreat Detection Biodetection July 31, 2024 …
Lacking Diagnostic Tools, Malaria Becomes Catch-All Diagnosis for Febrile Diseases in W. Africa Biodetection June 7, 2024 …
Pandemic Accord Negotiations Fall Short, Outcomes to Be Shared at World Health Assembly Health Security May 24, 2024 …
New Strategic Framework for Mpox Outbreak Control and Medical Countermeasures Infectious Diseases May 24, 2024 …
Haiti’s Collapsing Health System in a Time of Conflict and Cholera Infectious Diseases May 24, 2024 …
Does the Detection of Influenza D Antibodies in Dogs Pose a Risk to Humans? Pathogens April 26, 2024 …
AMR Crisis: Widespread Overuse of Antibiotics in Hospitalized COVID-19 Patients Antimicrobial Resistance April 26, 2024 …
Soligenix Extends Patent Protection for Filovirus Vaccine Platform to UK and South Africa Industry News April 25, 2024 …
Pandemic Catalyzed Growing Acceptance to Withhold Patient Care Due to Safety Concerns Health Security April 24, 2024 …